Magali J. Fontaine

Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study

Pablo Tebas, Marie‐Carmelle Elie, Ednan K. Bajwa et al. · The Lancet Respiratory Medicine · 2017 · 118 citations · Full text

Life Sciences, Immunology, Infectious Diseases +6

Making thawed universal donor plasma available rapidly for massively bleeding trauma patients: experience from the Pragmatic, Randomized Optimal Platelets and Plasma Ratios (PROPPR) trial

Deborah J. Novak, Yu Bai, Rhonda Cooke et al. · Transfusion · 2015 · 86 citations · Full text

Medicine, Hematology, Surgery +17

Older Blood Is Associated With Increased Mortality and Adverse Events in Massively Transfused Trauma Patients: Secondary Analysis of the PROPPR Trial

Allison R. Jones, Rakesh P. Patel, Marisa B. Marques et al. · Annals of Emergency Medicine · 2018 · 58 citations · Full text

Medicine, Geriatric Medicine, Hematology +17

Human Mesenchymal Stromal Cell (MSC) Characteristics Vary Among Laboratories When Manufactured From the Same Source Material: A Report by the Cellular Therapy Team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative

David F. Stroncek, Ping Jin, David H. McKenna et al. · Frontiers in Cell and Developmental Biology · 2020 · 57 citations · Full text

Pharmacy, Bioengineering, Cell Biology +17

Age of blood as a limitation for transfusion: potential impact on blood inventory and availability

Magali J. Fontaine, Yenho T. Chung, Feryal Erhun et al. · Transfusion · 2010 · 53 citations

Medicine, Hematology, Patient Safety +16